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Abstract—The accurate diagnosis of Alzheimers disease (AD)
is essential for patient care and will be increasingly important as
disease modifying agents become available, early in the course
of the disease. Although studies have applied machine learning
methods for the computer aided diagnosis (CAD) of AD, a
bottleneck in the diagnostic performance was shown in previous
methods, due to the lacking of efficient strategies for representing
neuroimaging biomarkers. In this study, we designed a novel
diagnostic framework with deep learning architecture to aid the
diagnosis of AD. This framework uses a zero-masking strategy for
data fusion to extract complementary information from multiple
data modalities. Compared to the previous state-of-the-art work-
flows, our method is capable of fusing multi-modal neuroimaging
features in one setting and has the potential to require less
labelled data. A performance gain was achieved in both binary
classification and multi-class classification of AD. The advantages
and limitations of the proposed framework are discussed.
Index Terms—Alzheimer’s Disease, Classification, Neuroimag-
ing, MRI, PET, Deep Learning.
I. INTRODUCTION
ALZHEIMER’s disease (AD) is a degenerative brain dis-order which is characterised by a progressive dementia
that is charactered by the degeneration of specific nerve cells,
presence of neuritic plaques and neurofibrillary tangles [1].
A decline in memory and other cognitive functions are the
usual early syndromes. AD will be a global burden over the
coming decades, due to the increasing age of societies. It was
reported that in 2006 there were 26.6 million AD cases in
the world, including about 56% of the cases that are at the
early stage. In 2050, the population of the AD patients is
predicted to grow fourfold to 106.8 million [2]. The precise
diagnosis of AD was considered as a difficult clinical task with
insufficient specificity because the evaluation of the mental
status cannot be made when the consciousness is impaired.
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Another difficulty is caused by the confusion of other non-
AD dementia syndromes. Mild Cognitive Impairment (MCI),
a prodromal stage of AD, has drawn attention of researchers
recently, because it is useful for clinical trials. Though MCI
does not notably interfere with daily activities, it has been
constantly proven that MCI patients are at a high risk of AD
progression [3]. To conduct prediction of transition risk of
MCI, MCI subjects can be further categorised as MCI Convert-
ers (cMCI) and MCI Non-converters (ncMCI). It is essential
to detect the early stages as well as across the full spectrum
of AD progression, therefore patients are allowed to control
the risk factors, for example isolated systolic hypertension [4],
[5], before irreversible brain damage develops. Neuroimaging
techniques, such as Magnetic Resonance Imaging (MRI) [6]–
[11] and Positron Emission Tomography (PET) [12]–[18],
have been widely used in the assessment of AD, along with
many other non-imaging biomarkers [6], [19], [20].
Machine learning methods have been proposed to aid the di-
agnosis of AD. Pre-computed medical descriptors were widely
used to represent biomedical images. Approximate measure-
ments, such as the volume [21] and the cerebral metabolic
rate of glucose (CMRGlc) [22], were normally computed from
segmented 3D brain regions of interest (ROI), and were used
for AD classification with Support Vector Machine (SVM)
[23], Bayesian method [24] or other methods [25], [26].
However, there are several constraints in such work-flows. The
methods based on these conventional machine learners often
work well in binary classification, such as categorising AD
subjects from normal control (NC) subjects, but it is difficult
to extend them to multi-classes [27]. As a result, although
the diagnosis of AD should be naturally modelled as a multi-
class classification problem, it was normally simplified as a
set of binary classification tasks [23], [28] which distinguish
AD or MCI subjects from NC subjects. Another constraint is
the embedding of clinical prior knowledge. A method based
on the graph cut algorithm was proposed recently by Liu
et al. [10]. This work-flow adjusted the graph cut algorithm
with parameters corresponding to the relationships between
different stages of AD. Though such customisation tends to
yield promising classification results, the work-flow can be
sensitive to changes in the dataset and can be difficult to
extend to a large scale. Another challenge of AD diagnosis
is to represent the original biomarkers in an unsupervised
approach. Some frameworks reduces the dimensionality of
each type of biomarker in a supervised way and then fuses
the feature modalities to form a new feature space [29]–
[31]. Such work-flows depend heavily on the quantity of the
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labelled samples, which are difficult to achieve. Separating the
dimensionality reduction and the data fusion may also result
in losing complementary information.
We believe the previous work-flows can be optimised by
designing a new framework to efficiently represent the multi-
modal biomarkers and effectively characterise the multiple
stages of AD. The conventional feature engineering work-
flows with shallow structures and affine data transformation
often simply result in feature repetition or dimensionality
selection. As shown in many recent studies, deep data repre-
sentation can be more efficient than the shallow architectures
in multi-class classification by disentangling complex patterns
in the inputs [32]–[36]. Deep learning architectures extract
high-level features progressively via several layers of feature
representations [37]. The high-level features tend to be more
separable in classification problems due to the sequential
transformations of the feature space.
Brosch and Tam, using MR, reported that multi-layered
learning structure was effective in capturing shape variations of
the brain regions that correlate with demographic and disease
information, such as the ventricle size [38]. In the framework
proposed by Suk et al. [39], one setting of stacked auto-
encoders (SAE) was trained for each image modality, then
the learnt high-level features were further fused with a multi-
kernel support vector machine (MKSVM). In such work-flows,
the single-modal high-level features were learnt regardless of
the other modalities, which may ignore the synergy between
different modalities in the feature learning.
In this study, we propose a novel framework of multi-class
AD diagnosis with deep learning architecture embedded which
benefits from the synergy between multi-modal neuroimaging
features. The framework is constructed with an SAE and a
softmax logistic regressor. The auto-encoders represent the
data in an unsupervised way which can be extended to use
unlabelled data in practice. The proposed framework is capable
of data fusion when multi-modal neuroimaging image data are
available. Following the concepts of de-noising auto-encoder
[40], we applied the zero-mask strategy on bimodal deep
learning tasks to extract the synergy between different image
modalities. By randomly hiding one modality of the training
set, the hidden layers of the neural network tend to be able
to reconstruct the missing modality with corrupted inputs
by inferring the correlations between multi-modal features.
With the softmax regression embedded in the deep learning
architecture, our framework is capable of classifying AD
patients into four AD stages.
The rest of this paper is organised as follows. We introduce
the proposed learning framework and the training strategies
in Section II. The experiments and results of this study are
presented in Section III. We discuss the proposed framework
and conclusions of the paper in sections IV and V.
II. METHODOLOGY
The pipeline of the proposed framework is illustrated in
Fig. 1. In this study, MR and PET data are used as two
input neuroimaging modalities. All collected brain images are
firstly pre-processed and segmented into 83 functional ROI,
and a set of descriptors are computed from each ROI. The
dataset is divided into a training set and a testing set. We
perform Elastic Net [9], [41], [42] only on the training samples
to select the discriminative subset of the feature parameters.
A multi-layered neural network consisting of several auto-
encoders is then trained using the selected feature subset
in the training dataset. Each layer of the network obtains a
higher level of abstraction of the previous layer with non-linear
transformation [43]–[45]. The softmax layer is added on the
top of the stacked auto-encoders for classification. The trained
network is then evaluated with the labelled testing samples.
A. Data Acquisition and Feature Extraction
The neuroimaging data used in this study were obtained
from the Alzheimers Disease Neuroimaging Initiative (ADNI)
database1 [46]. This database was launched in 2003 by the
National Institute on Aging (NIA), the National Institute of
Biomedical Imaging and Bioengineering (NIBIB), the Food
and Drug Administration (FDA), private pharmaceutical com-
panies and non-profit organisations as a 5-year public part-
nership. The primary purpose of ADNI project was to study
the effects of combining multiple biomarkers, such as MRI,
PET and CSF data accompanied with neuropsychological
assessments, to predict the progression of MCI and early AD.
Around 200 normal instances and 400 MCI instances were
followed for 3 years, 200 AD patients were followed within 2
years. Determining the sensitive biomarkers to the progression
of AD might also aid the clinicians to discover new treatments,
as well as other possible biomedical exploration.
We obtained two datasets from ADNI. For the dataset
with only MR images, 816 age and sex matched subjects
were recruited from the ADNI repository and a T1-weighted
MR image was acquired from each subject. We excluded 20
subjects with multiple conversions or reversions as well as
21 MCI subjects whose data were incomplete. We labelled
the MCI subjects that converted to AD from 0.5 to 3 years
from the first scan as MCI converters (cMCI), otherwise the
MCI subjects were labelled as MCI non-converters (ncMCI).
The normal subjects and the AD patients were labelled as
Normal Control (NC) and Alzheimers Disease (AD) [10].
All raw MR images were corrected following the ADNI
MR image protocol, and were non-linearly registered to the
ICBM 152 template [47] using the Image Registration Toolkit
(IRTK) [48]. Only 17 images were excluded because of the
intolerable distortion. Finally, 758 MR subjects were reserved
for the experiments conducted in this study, including 180 AD
subjects, 160 cMCI subjects, 214 ncMCI subjects and 204
normal ageing control subjects.
For the dataset with multi-modal data fusion, 331 age and
sex matched subjects were selected from the baseline cohort,
including 77 NC-, 102 ncMCI-, 67 cMCI-, 85 AD-subjects
with both MR and PET data available. Each instance was
associated with T1-weighted volumes and FDG-PET images.
All the 3D images were pre-processed with the similar work-
flow described earlier for MR images. The PET images were
1The database is available at adni.loni.ucla.edu
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Fig. 1. The proposed diagnostic framework of Alzheimer’s Disease with deep learning architecture embedded.
aligned to the corresponding MR image using FSL FLIRT
[49].
For each registered 3D image, 83 brain regions were
mapped in the template space using multi-atlas propagation
with enhanced registration (MAPER) approach [50]. The grey
matter volumes were extracted from MR images, same as in
[9], [10]. For PET images, we extracted the regional average
CMRGlc feature same as in [22], [51]. We then normalised
features to be between 0 and 1 to support the sigmoidal
decoders by shifting the negative values and rescaling.
B. Learning Framework
1) Pre-Training Stacked Auto-Encoders: We applied
stacked auto-encoders (SAE) [45], [52], [53] to learn the high-
level features in an unsupervised way as shown in Fig. 2.
Each auto-encoder framework encodes an input vector x into
a hidden representation y with an affine mapping followed by
non-linear sigmoidal distortion,
y = σ(Wx+ b) (1)
where σ is set as a sigmoid function σ(x) = 11+e−x ; W is a
weight matrix and b is a vector of bias terms. y is the encodings
that represent the original input x. The ideal case is that we can
maximally reconstruct x with only knowing y. The decoder
reconstructs the input vector from the hidden representation
by
x∗ = τ(W
′
y + b
′
) (2)
where τ is another sigmoidal filter; W
′
is the decoding
weights. The number of the hidden neurons determines the di-
mensionality of the encodings at each layer. By controlling the
number of hidden units, we can either perform dimensionality
reduction or learn over-complete features. The decoding results
in a reconstruction of input vector x with high probability of
P (x∗|x). Therefore the reconstruction loss can be minimised
by optimising the log likelihood,
L(x, x∗) ∝ −logP (x∗|x) (3)
Since the features extracted from MR images were real
valued and were normalised to a domain x ∈ [0, 1], we used
the mean squared error to measure the reconstruction loss
L(x, x∗). To prevent the auto-encoder from learning merely
an identity function, the objective function is regularised by
adding a weight decay, e.g.
L(W, b, x, x∗) = min
W,b
L(x, x∗) + λ‖W‖22 (4)
where ‖W‖22 is the weight decay that controls over-fitting.
Though the objective function is not convex, the gradients
of the objective function in Eq. (4) can be exactly computed by
error back-propagation algorithm. In this study we applied the
Non-Linear Conjugate Gradient algorithm to optimise Eq. (4)
[52].
Following the greedy layer-wised training strategy, rather
than training all the hidden layers of the unsupervised network
altogether, we train one auto-encoder with a single hidden
layer at a time [43]. When an auto-encoder is trained with the
features obtained from the previously trained hidden layers,
the hidden layer of the current auto-encoder is then stacked
on the trained network. After training all the auto-encoders, the
final high-level features are obtained by feed-forwarding the
activation signals through the stacked sigmoidal filters. When
unlabelled subjects are available, the unsupervised feature
learning can be performed with a mixture of the labelled and
the unlabelled samples.
2) Multi-Modal Data Fusion: When more than one image
modality are used for model training, modality fusion meth-
ods are required to discover the synergy between different
modalities. Shared representation can be obtained by jointly
training the auto-encoders with the concatenated MR and PET
inputs. The first shared hidden layer is used to model the
correlations between different data modalities. However the
simple feature concatenation strategy often results in hidden
neurons that are only activated by one single modality, because
the correlations of MR and PET are highly non-linear. Inspired
by Ngiam et al. [54], we applied the pre-training method with
a proportion of corrupted inputs which had only one modality
presented, following the de-noising concepts of training deep
architecture. One of the modalities is randomly hidden by
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Fig. 2. Illustration of the single-modal & multi-modal architectures of the
proposed framework.
replacing these inputs with 0; the rest of the training samples
are presented with both modalities. The hidden layer of the
first auto-encoder is trained to reconstruct all of the original
inputs from the inputs that are mixed with hidden modalities.
The original inputs and the corrupted inputs are propagated to
the higher layers of the neural network independently to obtain
both the clean representation and the noisy representation us-
ing the same neural network. Each higher layer is then trained
progressively to reconstruct the clean high-level representation
from the propagated noisy representation. Thus some of the
hidden neurons are expected to infer the correlations between
different neuroimaging modalities.
3) Fine-Tuning for AD Classification: For the the AD
diagnosis, we modelled the task as a four-class classification
problem containing four pre-defined labels: NC, cMCI, ncMCI
and AD). Although the features learnt by the unsupervised
network can also be transferred to a conventional classifier,
such as SVM, softmax logistic regression enables us to jointly
optimise the entire network via fine-tuning.
The features extracted by the unsupervised network are fed
to an output layer with softmax regression [55]. The softmax
layer uses a different activation function, which might have
non-linearity different from the one applied in previous layers.
The softmax filter is defined as
P (Y = i|x) = e
W
(s)
i
a+b
(s)
i∑
i e
W
(s)
i
a+b
(s)
i
(5)
where Y is the possible stages of AD progression; a is the
feature representation obtained from the last hidden layer of
the pre-trained network; W (s)i and b
(s)
i are the weight and bias
for the i-th possible decision. For example P (Y = ’cMCI’
|x(l)), is the probability that the patient is diagnosed as a MCI
converter. The label with the highest probability is selected as
the final diagnosis. Optimising softmax layer is similar to the
unsupervised network. The objective function of fine-tuning
the network with softmax layer is defined as
L(W, b,X, Y ) = min
W,b
J(X,Y ) + λ(s)‖W (s)‖22 (6)
where W and b are the weights and bias of the entire network,
including the pre-trained SAE and the softmax regression
layer; J(X,Y ) is the logistic regression cost between the
diagnosis generated with on the input features X and the pre-
labelled results Y ; λ(s) is the relative weight of the weight
decay on softmax layer, which can be tuned to control the
over-fitting problem. To fine-tune the pre-trained structure, the
softmax layer is then connected to the last hidden layer of
the unsupervised network. We then propagate the activation
signals through the entire neural network and optimise all the
parameters according to the classification loss as a supervised
neural network [43], [56] as shown in Fig. 2-A. When more
than one modality are used in training the supervised network,
a small proportion of the single modal inputs are dropped
out in a similar way described in Section II-B-2. The hidden
neurons are trained to make diagnosis even when one modality
is absent. This strategy is supposed to make some of the hidden
neurons at the first hidden layer easy to be activated by the
incoming weights from both modalities [54].
C. Feature Examination
Hidden neurons at the first layer of our network are trained
to catch different patterns of input subjects. In deep learning
tasks with general images the hidden neurons can be visualised
as
x
′
ij =
W
(l)
ij
‖W‖2 (7)
where x
′
ij is the input pattern that maximally activates the i-th
hidden neuron.
Unlike pixels, the patterns in biomarkers are brain ROI
measurements that may be non-trivial to be visualised. We
examined the representation quality by mapping the input
patterns produced by Eq. (7) back to a masked 3D MR image,
with 83 segmented ROIs. Each input x
′
ij corresponds to the
brain ROI where it was extracted. By splitting the pattern x
into m features (volumes, CMLGLc, etc.), we compute the
variance D(m)j of all of the same ROI, measuring how the
ROI activate different hidden neurons. When D(m)j is low, the
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biomarkers from region j are more effective for AD diagnosis
than the other regions. The overall feature stability Sj of the
j-th ROI can be computed as
Sj =
∑
m
∑
j D
(m)
j
D
(m)
j
(8)
S can be convolved with a Gaussian filter to enlarge the
distinctions between different ROIs. The brain ROIs with
relatively high stability score are considered as more effective
to the AD progression. These mappings on the MR image can
be examined with the clinical prior-knowledge to monitor the
performance of the feature learning network in the context of
AD diagnosis.
III. EXPERIMENTS AND RESULTS
A. Visualisation of High-level Biomarkers
With the feature examination method described in Section
II-C, we calculated the stability score of each brain ROI and
mapped the stability score to a masked 3D MR image (83
ROIs) of a Normal Control subject as shown in Fig. 3. The
distinctions between various ROIs were clearly visualised. The
darker regions tend to be more sensitive to the progression of
AD and MCI than the lighter ROIs, since features extracted
from these ROIs tend to benefit all the hidden neurons equally.
The light regions are not denoted to be totally trivial, but
carrying less predictive information.
B. Performance Evaluation
We compared the proposed framework with the widely
applied methods using the single-kernel SVM and the multi-
kernel SVM (MKSVM) [23], [28]. To evaluate the proposed
data fusion method, we compared the zero-mask method
to the architecture proposed in [39] that trains two stacked
auto-encoders independently and then fuses the high-level
features with MKSVM after each SAE is fine-tuned. All of the
experiments were evaluated with the same features extracted
from MR images and PET images as described in Section
II-A.
The proposed framework was implemented on Matlab
2013a. The SVM-based experiments were performed using
LIBSVM [58]. The multi-kernel SVM was implemented by
using precomputed kernels and fusing the multiple kernels
with relative weights.
The evaluation was conducted by using 10-fold cross-
validation. In experiments including multiple modalities, we
compared the performance with only single modal data, MR
or PET, and the data fusion methods with both modalities.
To avoid the ’lucky trials’, we randomly sampled the training
and testing instances from each class to ensure they have
similar distributions as the original dataset. The entire network
was trained and fine-tuned with the 90% of data and then
tested with the rest of samples in each validation trial. The
hyper-parameters of all compared methods were chosen in
each validation trial using the approx search in log-domain to
obtain the best performed model [59]. Two hidden layers were
used in all neural network based experiments because adding
Fig. 3. The image was generated using 3D Slicer (V4.3) [57]. The stability
map denotes that the darker ROIs tend to be more affected by AD, hence
more sensitive to the AD progression than the brighter regions. The features
extracted from the darker areas are also considered as more stable predictors
for our deep learning model and tend to be beneficial to all of the hidden
neurons in the neural network.
additional hidden layers did not show further improvements on
AD classification. It is reasonable to assume that 2 non-linear
transformations could be ideal to represent the neuroimaging
features for AD classification. The number of neurons at
hidden layers were chosen between 30 to 200 according to
the classification performance in each fold. In each neural
network, hidden layers shared the same number of hidden
neurons [60]. The MKSVM was trained with the training
samples. Following the work-flow in [23], the relative weights
of each kernel in MKSVM were chosen through a coarse-grid
search with a step size of 0.1. In the experiments that used
MKSVM for fusing two SAE networks, each SAE was firstly
pre-trained and fine-tuned with the training data, and then the
high-level features obtained from each network were fused
with MKSVM with the procedure stated before.
1) Experiments on MR (758 Subjects): We firstly evaluated
the proposed framework with 758 3D MR images. Since only
one modality is presented, no modality fusion strategy was
used in both SVM and the proposed method.
The performance of binary classification (NC vs. AD and
NC vs. MCI) is displayed in Table I. The first two columns are
precisions on individual classes. The following three columns/
are the overall performance including accuracy, sensitivity,
specificity. The proposed method (SAE) outperformed SVM in
classifying AD subjects from the NC subjects by leading the
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TABLE I
THE PERFORMANCE (%) OF BINARY AD CLASSIFICATION WITH MR-ONLY SAMPLES.
NC vs. AD
Methods NC AD ACC SEN SPE
SVM 82.95± 8.57 80.16± 6.46 81.04± 6.28 82.83± 6.02 78.89± 14.66
SAE 82.23± 6.54 84.31± 7.36 82.59± 5.33 86.83± 6.83 77.78± 10.83
NC vs. MCI
Methods NC MCI ACC SEN SPE
SVM 62.39± 4.87 74.81± 4.34 71.27± 3.26 47.02± 12.37 84.50± 4.25
SAE 67.44± 13.14 75.80± 3.58 71.98± 5.48 49.52± 13.68 84.31± 13.15
TABLE II
THE PERFORMANCE (%) OF MULTI-CLASS AD CLASSIFICATION WITH MR-ONLY SAMPLES.
Methods NC ncMCI cMCI AD ACC SEN SPE
SVM 46.96± 3.95 42.95± 10.80 37.88± 10.18 44.62± 8.04 44.45± 3.07 75.00± 9.04 68.59± 5.13
SAE 52.40± 8.43 41.25± 7.16 38.71± 23.18 46.89± 4.40 46.30± 4.24 66.14± 10.57 77.78± 4.48
TABLE III
THE PERFORMANCE (%) OF THE BINARY AD CLASSIFICATION WITH MR AND PET.
NC vs. AD
Methods NC AD ACC SEN SPE
SVM-MR 87.83± 11.81 84.06± 10.42 84.67± 8.45 80.54± 11.59 88.33± 12.19
SVM-PET 84.58± 7.02 87.57± 10.12 84.60± 4.05 84.11± 12.86 84.58± 9.07
MKSVM 89.68± 5.67 91.50± 9.37 90.11± 5.57 89.64± 11.43 90.56± 4.76
SAE-MR 88.28± 11.68 88.74± 10.82 87.79± 9.12 87.32± 11.19 88.47± 12.19
SAE-PET 83.27± 12.44 85.91± 10.73 83.53± 9.80 82.86± 15.59 83.75± 12.41
SAE-CONCAT 88.67± 12.84 92.56± 8.35 90.15± 9.54 92.14± 9.08 88.19± 12.72
2SAE-MKSVM 91.35± 8.15 92.42± 8.81 91.40± 6.82 90.89± 10.40 91.67± 7.40
SAE-ZEROMASK 90.38± 7.36 92.89± 6.17 91.40± 5.56 92.32± 6.29 90.42± 6.93
NC vs. MCI
Methods NC MCI ACC SEN SPE
SVM-MR 67.52± 14.15 83.92± 7.56 77.70± 5.27 62.50± 20.11 84.60± 6.60
SVM-PET 62.66± 22.67 77.17± 4.78 72.35± 8.67 45.54± 10.23 84.60± 10.94
MKSVM 70.85± 17.69 80.16± 3.40 76.88± 5.83 52.14± 8.56 88.16± 8.73
SAE-MR 65.56± 24.61 76.86± 5.59 74.02± 7.58 40.36± 15.63 89.26± 7.61
SAE-PET 50.69± 22.53 77.12± 7.51 70.00± 9.33 46.96± 19.12 80.44± 8.42
SAE-CONCAT 73.56± 16.55 80.00± 4.94 77.65± 5.18 49.46± 14.35 90.51± 7.09
2SAE-MKSVM 90.42± 11.46 73.85± 10.01 77.90± 5.18 61.43± 18.99 92.92± 7.64
SAE-ZEROMASK 81.95± 14.99 83.88± 4.99 82.10± 4.91 60.00± 13.93 92.32± 8.74
TABLE IV
THE PERFORMANCE (%) OF MULTI-CLASS AD CLASSIFICATION WITH MR AND PET.
Methods NC ncMCI cMCI AD ACC SEN SPE
SVM-MR 49.74± 8.79 44.58± 14.91 46.45± 31.63 53.74± 10.20 47.74± 1.82 66.43± 14.46 78.78± 8.13
SVM-PET 30.30± 20.15 36.90± 11.63 45.79± 27.08 50.30± 7.00 42.60± 2.90 35.36± 23.00 79.95± 8.33
MKSVM 47.71± 12.73 52.76± 19.33 38.17± 31.94 53.81± 6.81 48.65± 4.29 61.07± 18.95 79.86± 6.43
SAE-MR 47.80± 17.97 40.39± 9.46 45.08± 24.95 56.33± 14.03 45.61± 8.31 48.04± 14.97 82.69± 7.88
SAE-PET 41.79± 11.76 35.17± 10.10 41.06± 10.06 54.25± 11.79 42.91± 6.63 43.04± 17.45 82.26± 5.36
SAE-CONCAT 49.21± 14.74 43.54± 9.43 49.62± 9.66 56.35± 14.21 48.96± 5.32 46.61± 22.04 84.63± 8.51
2SAE-MKSVM 53.86± 11.47 52.08± 18.65 53.17± 26.63 55.58± 13.06 51.39± 5.64 66.25± 18.34 82.66± 6.16
SAE-ZEROMASK 59.07± 19.74 52.21± 11.84 40.17± 14.42 64.07± 15.24 53.79± 4.76 52.14± 11.81 86.98± 9.62
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overall accuracy (82.59%) and overall sensitivity (86.83%).
The overall specificities between these two methods were
very closed (78.89% and 77.78%). The proposed method
outperformed SVM in all overall performance measurements
of classifying NC from MCI. The proposed method achieved
5% higher precision on classifying the normal control subjects.
The performance of multi-class classification is displayed
in Table II. The first four columns are the precisions of
the individual classes and the following three are the overall
performance. The proposed method performed better preci-
sions than SVM in three classes (52.40% on NC, 38.71% on
cMCI and 46.89% on AD). The proposed method leads in the
overall accuracy (46.30%) and overall specificity (77.78%).
SVM achieved higher sensitivity (75.00%). In summary, our
proposed method outperformed the state-of-the-art SVM-based
methods in most of the performance measurements in both
binary and multi-class AD classification problems when only
MR data are presented.
2) Experiments on MR and PET (331 Subjects): There are
totally 331 subjects with both MR and PET data available. We
firstly evaluated the performance of SVM and the proposed
SAE based method with only MR images (SVM-MR, SAE-
MR) or PET images (SVM-PET, SAE-PET). The performance
of fusing modalities with multi-kernel SVM is shown as
MKSVM. For deep learning methods, we compared the pro-
posed zero-masking training strategy (SAE-ZEROMASK) to
the simple feature concatenation (SAE-CONCAT).
The binary classification performance is displayed in Ta-
ble III. It can be observed that the experiments with both
modalities (MKSVM, SAE-CONCAT and SAE-ZEROMASK)
yielded better performance than those with only single modal-
ity in both binary classification tasks. SAE-CONCAT out-
performed MKSVM slightly in the overall accuracy (90.15%
- 90.11% and 77.65% - 76.88%). It can be observed that
when the proposed SAE-ZEROMASK method is used, the
performance is enhanced in all measurements comparing to
SAE-CONCAT. MKSVM performed slightly higher speci-
ficity in classifying NC and AD comparing to ZERO-MASK.
Though SVM-MR achieved slightly higher precision (83.92%)
on MCI, it is reasonable to assume this performance may
be due to an unbalanced decision making (only 67% on
NC). Among all the methods, SAE-ZEROMASK achieved
the most balanced performance in the classification between
NC and MCI (81.95% on NC and 83.88% on AD), which is
relatively difficult when MCI occupies a big proportion of the
dataset (169 out of 246). The proposed data fusion method
SAE-ZEROMASK with only one neural network achieved
comparable performance with 2SAE-MKSVM, which fuses
two high-level feature matrices from two independently trained
networks. The accuracy of 2SAE-MKSVM was not obviously
higher than that of simple feature concatenation (77.90% to
77.65%), because it was observed in the experiments the
MKSVM added for feature fusion only preserved the higher
accuracy achieved by a single modal network in some of the
validation trials.
The performance of the multi-class classification is shown in
Table IV. The proposed framework with the corrupted inputs
(SAE-ZEROMASK) leads the overall accuracy and specificity
(53.79% and 86.98%). Deep learning based methods (SAE-
CONCAT and SAE-ZEROMASK) lead the precision on NC,
cMCI and AD. The precision of cMCI was constrained by the
quantity of cMCI instances (67 out of 331) and was effected by
its sibling class ncMCI with 102 instances. For ncMCI the pre-
cision achieved by SAE-ZEROMASK and MKSVM were very
closed. Comparing to the simple feature concatenation (SAE-
CONCAT), SAE-ZEROMASK increased the overall accuracy
by about 5%. SAE-ZEROMASK also outperformed the other
data fusion option 2SAE-MKSVM in the overall accuracy and
specificity. SVM-based methods tend to have better sensitivity.
IV. DISCUSSION
A. Model Designing and Training
Studies have shown that learning architecture with multi-
layered non-linear representations of the original data would
yield meaningful features for classification [56], [61]–[63]. For
accurate diagnosis in AD subjects, we investigated the use
of multi-layered representations of neuroimaging biomarkers
on AD classification. Our results showed that multi-layered
structure can be used to distinguish MR and PET subjects
along the spectrum of AD progression with higher accuracy
than conventional shallow architectures. The performance of
classification primarily benefited from the depth (a notion
derived from complexity theory) of the learning architec-
ture, which can be illustrated as a sequence of non-linear
transformations of the feature space. During fine-tuning, the
neuroimaging feature space is distorted and folded to min-
imise the classification loss on the training data. Thus, after
several layers of transformations, the inseparable samples
would become separable in the learnt high-level feature space.
Compared to traditional methods, the proposed framework is
more powerful in extracting the complex correlations between
neuroimaging ROI based biomarkers as well as different
feature modalities. Another motivation of using multi-layered
structure for AD diagnosis is to reuse the high-level features
for semi-supervised learning [64]. Besides the supervised data
fusion or dimensionality reduction [29], the proposed work-
flow can be easily extended to use unlabelled neuroimaging
data.
We combined different data modalities with the proposed
zero-mask fusion strategy by propagating noisy signals with
one modality randomly hidden. The auto-encoders were
trained to reconstruct the original incoming signals with the
corrupted incoming signals. We also tried to avoid training
separate neural networks on different data modalities, because
this may ignore the complementary information during feature
learning. The training subjects with one hidden modality tend
to force some neurons to be sensitive to MR and PET inputs,
which makes the zero-mask fusion network different as it has
two independent feature learning networks. It was noticeable
that 2SAE+MKSVM also achieved an overall classification
accuracy of 91.4% and a higher specificity of 91.67% in
the binary classification of NC and AD. It may indicate
that when relatively larger margins exist between different
feature clusters, the binary decision boundaries might be
similar between both feature fusion methods. Observing the
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experimental results with non-convertible and convertible MCI
subjects involved, we assume that the proposed zero-mask
method may have more advantages when subtler differences
and more outliers are included in a noisy training set.
Instead of using raw image patches for the medical feature
learning, we applied the feature engineering pipeline to extract
the initial ROI measurements of MR and PET images as
inputs. The differences between 3D medical images of AD
related patients tend to be subtle and the variance tends to
be large. From this perspective, the hidden neurons of the
network decision system can also be interpreted as automati-
cally encoded inferences of diagnostic rules [65]. Our exper-
iments showed that when using ROI precomputed features,
the unsupervised network achieved the best performance with
two hidden layers in pre-training. This means that relatively
shallower architectures are practically required when using
the approximately measured imaging features, compared with
the learning tasks which use raw images as inputs [38]. The
networks with the same number of neurons in all hidden layers
often performed better in our experiments. We found that
both over-completed manifolds or low-dimensional manifolds
yielded effective features for AD classification. The number
of hidden neurons was chosen according to different training
sets.
The feature selection, using Elastic Net, enhanced the per-
formance of all examined methods. It helped control the over-
fitting caused by the noisy and redundant feature parameters.
Notably, the majority of the selected feature parameters were
consistently chosen by Elastic Net. The validation trials,
with fewer chosen feature parameters, tended to have higher
generalisation errors, which might be due to the biased outliers
that were included in the training set.
Although the extracted features can be used by some other
conventional classifiers, such as SVM, we connected an output
layer with softmax regression to the unsupervised network.
With a different non-linearity from the one used in other
layers, softmax regression corresponded to multinomial log-
output-variables. As a result, it is capable of classifying
samples among several AD stages; it also simplified the fine-
tuning phase of training because the softmax layer can be
jointly optimised with the hidden layers. We also investigated
the framework designs of transferring the fine-tuned features to
popular classifiers other than the embedded softmax regressor.
It was interesting to see that, taking as input the same high-
level features learnt by our deep learning network, all of
the investigated classifiers tended to make highly consistent
decisions.
B. Limitations and Future Work
Considering the limited quantity of the available neu-
roimaging data, we assume that the synergy between differ-
ent biomarkers can be further extracted with more training
samples which may have smaller variance. The proposed data
fusion strategy follows the de-noising fashion of training auto-
encoders, which theoretically increased the difficulty of feature
learning, but controlled the over-fitting. Although the predicted
probability distribution of the 4-class AD classification may
be of more practical use in a decision-making system, the
performance that we achieved with the available dataset should
be improved before multi-class classification frameworks are
applied to clinical use. All the methods that we compared our
methodology to, tended to over-fit, but had high accuracy on
the training set and low accuracy on the testing set. Since
the multi-modal learning architectures with neural networks
(2SAE-MKSVM and SAE-ZEROMASK) are parametric mod-
els, we assume that they may have the potential to achieve
better diagnostic accuracy on multi-class AD diagnosis when
larger datasets are available. This will allow better extraction
of subject-independent features with lower variance.
V. CONCLUSION
We propose a novel framework for the diagnosis of AD with
deep learning embedded. The framework can distinguish four
stages of AD progression with less clinical prior knowledge
required. Since the unsupervised feature representation is
embedded in this work-flow, it has potential to be extended
to more unlabelled data for feature engineering in practice.
In the unsupervised pre-training stage, we used stacked auto-
encoders to obtain high-level features. When more than one
neuroimaging modality was used, we applied a zero-masking
strategy to extract the synergy between different modalities
following a de-noising fashion. After the unsupervised feature
engineering, a softmax regression was used. We used a novel
method of visualising high-level brain biomarkers to analyse
the high-level features that were extracted.
The proposed framework was evaluated with AD classifica-
tion between stage two and four. Based on MR and PET ADNI
data repository, our framework outperformed the state-of-the-
art SVM based method and other deep learning frameworks.
We argue that, therefore, the proposed method can be a power-
ful means to represent multi-modal neuroimaging biomarkers.
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